**Question:** Which of the following collagen disorders is NOT commonly associated with pulmonary fibrosis?

A. Scleroderma
B. Ehlers-Danlos syndrome
C. Marfan syndrome
D. Ankylosing spondylitis

**Core Concept:** Collagen disorders are a group of diseases characterized by abnormal accumulation or distribution of collagen in the body, leading to various tissue and organ dysfunctions. Pulmonary fibrosis is the excessive scarring and thickening of lung tissue, impairing lung function.

**Why the Correct Answer is Right:** Ankylosing spondylitis is primarily characterized by inflammation and fusion of the spine joints, which is distinct from pulmonary fibrosis. While it can cause respiratory symptoms, it is not commonly associated with pulmonary fibrosis.

**Why Each Wrong Option is Incorrect:**

A. Scleroderma (Systemic Sclerosis): A collagen disorder characterized by excessive collagen production, leading to skin thickening and internal organ fibrosis, including the lungs. Pulmonary fibrosis is a common complication of scleroderma.
B. Ehlers-Danlos syndrome: A group of genetic disorders affecting collagen synthesis and structure, leading to skin laxity, joint hypermobility, and increased risk of organ rupture. Although Ehlers-Danlos syndrome can present with pulmonary fibrosis, it is less commonly associated compared to scleroderma.
C. Marfan syndrome: A genetic disorder affecting connective tissue, causing lengthened joints, aortic root dilation, and other organ involvement. While pulmonary fibrosis can occur in Marfan syndrome, it is not as commonly linked to the condition as scleroderma and Ehlers-Danlos syndrome.
D. Ankylosing spondylitis: As mentioned above, ankylosing spondylitis primarily affects the spine and is not commonly associated with pulmonary fibrosis.

**Clinical Pearl:** Ankylosing spondylitis is distinct from the other collagen disorders mentioned, which are more commonly associated with pulmonary fibrosis. Ankylosing spondylitis primarily affects the spine, whereas scleroderma, Ehlers-Danlos syndrome, and Marfan syndrome have a higher risk of pulmonary fibrosis.